View in EDS

Recombinant Luteinizing Hormone (rLH) Induces Ovarian Angiogenesis In Vivo via Modulation of the Expression of Follicular Vascular Endothelial Growth Factor (VEGF)-A165 and Its Soluble Receptor sFlt-1/VEGFR-1 but not Placental Growth Factor (PlGF). A Prospective, Randomized, Double-Blind, Placebo-Controlled Study

Saved in:
Bibliographic Details
Title: Recombinant Luteinizing Hormone (rLH) Induces Ovarian Angiogenesis In Vivo via Modulation of the Expression of Follicular Vascular Endothelial Growth Factor (VEGF)-A165 and Its Soluble Receptor sFlt-1/VEGFR-1 but not Placental Growth Factor (PlGF). A Prospective, Randomized, Double-Blind, Placebo-Controlled Study
Authors: Gutman, G.1, Barak, V.1, Maslovitz, S.1, Amit, A.1, Lessing, J.B.1, Geva, E.1
Source: Fertility & Sterility. Sep2005 Supplement 1, Vol. 84, pS315-S316. 0p.
Database: Academic Search Ultimate
Description
ISSN:00150282
DOI:10.1016/j.fertnstert.2005.07.825